1. Bencova V, Bella V, Svec J. The dynamics of psychosocial burden development in breast cancer survivors: clinical success with psychosocial consequences. Klin Onkol 2011; 24(3): 203–208.
2. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs 2009; 25(4): 268–277.
3. Coufal O, Sporcrova I, Vrtelova P. What patients need to know before their breast cancer surgery. Klin Onkol 2011; 24(5): 343–347.
4. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353(1): 64–73.
5. Battaglia DE, Goodwin P, Klein NA et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 1996; 11(10): 2217–2222.
6. Maltaris T, Beckmann MW, Dittrich R. Review. Fertility preservation for young female cancer patients. In Vivo 2009; 23(1): 123–130.
7. Gracia CR, Ginsberg JP. Fertility risk in pediatric and adolescent cancers. Cancer Treat Res 2007; 138: 57–72.
8. West ER, Zelinski MB, Kondapalli LA et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer 2009; 53(2): 289–295.
9. Johnson J, Canning J, Kaneko T et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428(6979): 145–150.
10. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98(13): 890–896.
11. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7(6): 535–543.
12. Meirow D, Epstein M, Lewis H et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001; 16(4): 632–637.
13. Wetzels JF. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? Neth J Med 2004; 62(10): 347–352.
14. Hancke K, Isachenko V, Isachenko E et al. Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy-clinical approach and unsolved issues. Support Care Cancer 2011; 19(12): 1909–1919.
15. Larsen EC, Müller J, Schmiegelow K et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88(11): 5307–5314.
16. Shalet SM. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev 1980; 7(3): 141–152.
17. Schilsky RL, Sherins RJ, Hubbard SM et al. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin’s disease. Am J Med 1981; 71(4): 552–556.
18. Donnez J, Dolmans MM. Preservation of fertility in females with haematological malignancy. Br J Haematol 2011; 154(2): 175–184.
19. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005; 11(1): 69–89.
20. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005; 34: 64–68.
21. Bath LE, Anderson RA, Critchley HO et al. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod 2001; 16(9): 1838–1844.
22. Goodwin T, Delasobera BE, Fisher PG. Reproductive health issues in survivors of childhood and adult brain tumors. Cancer Treat Res 2009; 150: 215–222.
23. Letourneau JM, Ebbel EE, Katz PP et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012; 118(6): 1710–1717.
24. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 1999; 33(1): 24–28.
25. Letourneau JM, Ebbel EE, Katz PP et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2012; 118(7): 1933–1939.
26. Bath LE, Wallace WH, Shaw MP et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18(11): 2368–2374.
27. Larsen EC, Müller J, Rechnitzer C et al. Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Hum Reprod 2003; 18(2): 417–422.
28. Blakely LJ, Buzdar AU, Lozada JA et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 2004; 100(3): 465–469.
29. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989; 43(3): 399–402.
30. Critchley HO. Factors of importance for implantation and problems after treatment for childhood cancer. Med Pediatr Oncol 1999; 33(1): 9–14.
31. Green DM, Zevon MA, Lowrie G et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991; 325(3): 141–146.
32. Nagarajan R, Robison LL. Pregnancy outcomes in survivors of childhood cancer. J Natl Cancer Inst Monogr 2005; 34: 72–76.
33. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008; 26(5): 753–758.
34. Dew JE, Wren BG, Eden JA. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 2003; 6(1): 45–52.
35. Barbera L, Fitch M, Adams L et al. Improving care for women after gynecological cancer: the development of a sexuality clinic. Menopause 2011; 18(12): 1327–1333.
36. Mok-Lin E, Missmer S, Berry K et al. Public perceptions of providing IVF services to cancer and HIV patients. Fertil Steril 2011; 96(3): 722–727.
37. Ernst E, Bergholdt S, Jørgensen JS et al. The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod 2010; 25(5): 1280–1281.
38. Sánchez–Serrano M, Crespo J, Mirabet V et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril 2010; 93(1): 268. e11–e13.
39. Sheikhi M, Hultenby K, Niklasson B et al. Clinical grade vitrification of human ovarian tissue: an ultrastructural analysis of follicles and stroma in vitrified tissue. Hum Reprod 2011; 26(3): 594–603.
40. Cobo A, Domingo J, Pérez S et al. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008; 10(5): 268–273.
41. Revel A, Revel-Vilk S, Aizenman E et al. At what age can human oocytes be obtained? Fertil Steril 2009; 92(2): 458–463.
42. Oktem O, Oktay K. Fertility preservation for breast cancer patients. Semin Reprod Med 2009; 27(6): 486–492.
43. Nogueira D, Staessen C, Van de Velde H et al. Nuclear status and cytogenetics of embryos derived from in vitro-matured oocytes. Fertil Steril 2000; 74(2): 295–298.
44. Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med 2011; 29(1): 24–37.
45. Trounson A, Anderiesz C, Jones G. Maturation of human oocytes in vitro and their developmental competence. Reproduction 2001; 121(1): 51–75.
46. Fadini R, Dal Canto MB, Mignini Renzini M et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online 2009; 19(3): 343–351.
47. Oktay KH. Options for preservation of fertility in women. N Engl J Med 2005; 353(13): 1418–1420.
48. Mikkelsen AL. Strategies in human in-vitro maturation and their clinical outcome. Reprod Biomed Online 2005; 10(5): 593–599.
49. Tang-Pedersen M, Westergaard LG, Erb K et al. Combination of IVF and IVM in naturally cycling women. Reprod Biomed Online 2012; 24(1): 47–53.